Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

RL Carhart-Harris, M Bolstridge, J Rucker, CMJ Day… - The Lancet …, 2016 - Elsevier

Abstract

Background Psilocybin is a serotonin receptor agonist that occurs naturally in some mushroom species. Recent studies have assessed the therapeutic potential of psilocybin for various conditions, including end-of-life anxiety, obsessive-compulsive disorder, and …

Last updated: Jul 27, 2020